You know that immunophenotyping is indispensable at every stage of drug development, from optimizing the design of your therapeutic to monitoring treatment response.
But you may face a nagging question: Should you use flow cytometry, the long-established gold standard? Or is epigenetic immune monitoring—known as an efficient, economically viable, convenient global solution—the better choice for your study?
Precision for Medicine’s latest whitepaper, To Flow or Not to Flow: Immune Cell Profiling in Translational Research, can help you decide. Written by a trio of Precision experts, it outlines the pros and cons of each modality, then provides a selection framework based on the stage of your study and your specific profiling goals.
Offered Free by: Precision Medicine Group, LLC
See All Resources from: Precision Medicine Group, LLC
